Moreira José M A, Gromov Pavel, Celis Julio E
Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
Mol Cell Proteomics. 2004 Apr;3(4):410-9. doi: 10.1074/mcp.M300134-MCP200. Epub 2004 Jan 21.
The 14-3-3 proteins constitute a family of abundant, highly conserved and broadly expressed acidic polypeptides that are involved in the regulation of various cellular processes such as cell-cycle progression, cell growth, differentiation, and apoptosis. One member of this family, the 14-3-3 isoform sigma, is expressed only in epithelial cells and is frequently down-regulated in a variety of human cancers. To determine the prevalence of 14-3-3 sigma silencing in bladder cancer progression, we have studied the expression of this protein in normal urothelium and bladder transitional cell carcinomas (TCCs) of various grades and stages using two-dimensional gel electrophoresis in combination with Western blotting and immunohistochemistry. We show that the expression of 14-3-3 sigma is down-regulated in invasive TCCs, particularly in lesions that are undergoing epithelial-to-mesenchymal conversion. Altered expression of 14-3-3 sigma in invasive TCCs is not due to increased externalization of the protein nor to an aberrant proliferative potential of neoplastic cells. Furthermore, we found that impaired 14-3-3 sigma expression is not associated with increased levels of the dominant-negative transcriptional regulator Delta Np63. Down-regulation of 14-3-3 sigma was confirmed by indirect immunofluorescence using a peptide-based rabbit polyclonal antibody specific for this protein. We also show that the expression of 14-3-3 sigma is highly up-regulated in pure squamous cell carcinomas. Taken together, these results provide evidence that deregulation of 14-3-3 sigma may play a key role in bladder cancer progression, in particular in differentiation events leading to epithelial-to-mesenchymal transition and stratified squamous metaplasia.
14-3-3蛋白构成了一个丰富、高度保守且广泛表达的酸性多肽家族,参与多种细胞过程的调控,如细胞周期进程、细胞生长、分化和凋亡。该家族的一个成员,14-3-3同工型sigma,仅在上皮细胞中表达,且在多种人类癌症中经常下调。为了确定14-3-3 sigma沉默在膀胱癌进展中的普遍性,我们使用二维凝胶电泳结合蛋白质印迹法和免疫组织化学,研究了该蛋白在正常尿路上皮以及不同分级和分期的膀胱移行细胞癌(TCC)中的表达。我们发现,14-3-3 sigma的表达在浸润性TCC中下调,尤其是在正在经历上皮-间质转化的病变中。浸润性TCC中14-3-3 sigma表达的改变并非由于该蛋白的细胞外分泌增加,也不是由于肿瘤细胞异常的增殖潜能。此外,我们发现14-3-3 sigma表达受损与显性负性转录调节因子Delta Np63水平升高无关。使用针对该蛋白的基于肽的兔多克隆抗体通过间接免疫荧光证实了14-3-3 sigma的下调。我们还表明,14-3-3 sigma的表达在纯鳞状细胞癌中高度上调。综上所述,这些结果提供了证据,表明14-3-3 sigma的失调可能在膀胱癌进展中起关键作用,特别是在导致上皮-间质转化和分层鳞状化生的分化事件中。